Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Nurix Therapeutics (NRIX) Return on Invested Capital: 2020-2021

  • Nurix Therapeutics' Return on Invested Capital was N/A to -0.21% in Q2 2021 from the same period last year, while for May 2021 it was -0.21%, marking a year-over-year change of. This contributed to the annual value of -0.38% for FY2020, which is N/A change from last year.
  • Nurix Therapeutics' Return on Invested Capital amounted to -0.21% in Q2 2021, which was down 3.85% from -0.20% recorded in Q1 2021.
  • Nurix Therapeutics' Return on Invested Capital's 5-year high stood at -0.15% during Q4 2020, with a 5-year trough of -0.21% in Q2 2021.
  • Over the past 2 years, Nurix Therapeutics' median Return on Invested Capital value was -0.20% (recorded in 2021), while the average stood at -0.19%.